Optimal antimicrobial therapy and antimicrobial stewardship in sepsis and septic shock
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seok, Hyeri | - |
dc.contributor.author | Park, Dae Won | - |
dc.date.accessioned | 2021-08-31T22:37:00Z | - |
dc.date.available | 2021-08-31T22:37:00Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/61324 | - |
dc.description.abstract | The management of sepsis and septic shock remains challenging. The aim is to apply the optimal antimicrobial therapy and antimicrobial stewardship to patients in state of sepsis or septic shock. To reduce the mortality of sepsis and septic shock, it is critical to promptly administer the appropriate antibiotics with an accurate diagnosis. De-escalation is needed 48 to 72 hours after the first administration of antibiotics depending on the findings of causative pathogens. In the case of antibiotic resistance, the importance of an antibiotic stewardship program is increasingly being emphasized. Antimicrobial stewardship implies coordinated interventions designed to improve the appropriate use of antibiotics by promoting the selection of an optimal drug regimen such as dosing, duration of therapy, and route of administration. An antibiotic stewardship program may also be applied to patients of both sepsis and septic shock. Efforts such as the selection of appropriate empirical antibiotics, de-escalation, and determination of whether to stop antibiotics with procalcitonin may improve the clinical prognosis of patients with sepsis as well as the successful implementation of an antibiotic stewardship program. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.subject | ANTIBIOTIC-THERAPY | - |
dc.subject | INTENSIVE-CARE | - |
dc.subject | DE-ESCALATION | - |
dc.subject | CLINICAL-OUTCOMES | - |
dc.subject | BLOOD CULTURE | - |
dc.subject | ORGAN FAILURE | - |
dc.subject | PROCALCITONIN | - |
dc.subject | MORTALITY | - |
dc.subject | IMPACT | - |
dc.subject | RESISTANCE | - |
dc.title | Optimal antimicrobial therapy and antimicrobial stewardship in sepsis and septic shock | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seok, Hyeri | - |
dc.contributor.affiliatedAuthor | Park, Dae Won | - |
dc.identifier.doi | 10.5124/jkma.2019.62.12.638 | - |
dc.identifier.scopusid | 2-s2.0-85077430563 | - |
dc.identifier.wosid | 000503199600008 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.62, no.12, pp.638 - 644 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 62 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 638 | - |
dc.citation.endPage | 644 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002530481 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ANTIBIOTIC-THERAPY | - |
dc.subject.keywordPlus | INTENSIVE-CARE | - |
dc.subject.keywordPlus | DE-ESCALATION | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | BLOOD CULTURE | - |
dc.subject.keywordPlus | ORGAN FAILURE | - |
dc.subject.keywordPlus | PROCALCITONIN | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordAuthor | Sepsis | - |
dc.subject.keywordAuthor | Septic shock | - |
dc.subject.keywordAuthor | Anti-infective agents | - |
dc.subject.keywordAuthor | Anti-bacterial agents | - |
dc.subject.keywordAuthor | Antibiotic stewardship | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.